Folgen
Thomas Hussenet
Thomas Hussenet
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei inserm.fr
Titel
Zitiert von
Zitiert von
Jahr
Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling
I Malanchi, H Peinado, D Kassen, T Hussenet, D Metzger, P Chambon, ...
Nature 452 (7187), 650, 2008
7482008
Advances in tenascin-C biology
KS Midwood, T Hussenet, B Langlois, G Orend
Cellular and molecular life sciences 68 (19), 3175, 2011
3962011
SOX2 is an oncogene activated by recurrent 3q26. 3 amplifications in human lung squamous cell carcinomas
T Hussenet, S Dali, J Exinger, B Monga, B Jost, D Dembelé, N Martinet, ...
PLoS One 5 (1), e8960, 2010
3662010
Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model
F Saupe, A Schwenzer, Y Jia, I Gasser, C Spenlé, B Langlois, ...
Cell reports 5 (2), 482-492, 2013
1232013
Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model
F Saupe, A Schwenzer, Y Jia, I Gasser, C Spenlé, B Langlois, ...
Cell reports 5 (2), 482-492, 2013
1232013
Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer
R Redon, T Hussenet, G Bour, K Caulee, B Jost, D Muller, J Abecassis, ...
Cancer research 62 (21), 6211-6217, 2002
1182002
Tenascin-C Promotes Tumor Cell Migration and Metastasis through Integrin α9β1–Mediated YAP Inhibition
Z Sun, A Schwenzer, T Rupp, D Murdamoothoo, R Vegliante, O Lefebvre, ...
Cancer research 78 (4), 950-961, 2018
1142018
SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis
T Hussenet, S du Manoir
Cell Cycle 9 (8), 1480-1486, 2010
1122010
Tenascin-C orchestrates glioblastoma angiogenesis by modulation of pro-and anti-angiogenic signaling
T Rupp, B Langlois, MM Koczorowska, A Radwanska, Z Sun, T Hussenet, ...
Cell Reports 17 (10), 2607-2619, 2016
982016
Tenascin-C increases lung metastasis by impacting blood vessel invasions
Z Sun, I Velázquez-Quesada, D Murdamoothoo, C Ahowesso, A Yilmaz, ...
Matrix Biology, 2019
612019
Transmembrane domain targeting peptide antagonizing ErbB2/Neu inhibits breast tumor growth and metastasis
A Arpel, P Sawma, C Spenlé, J Fritz, L Meyer, N Garnier, ...
Cell reports 8 (6), 1714-1721, 2014
602014
Transmembrane domain targeting peptide antagonizing ErbB2/Neu inhibits breast tumor growth and metastasis
A Arpel, P Sawma, C Spenlé, J Fritz, L Meyer, N Garnier, ...
Cell reports 8 (6), 1714-1721, 2014
602014
AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients
B Langlois, F Saupe, T Rupp, C Arnold, M Van der Heyden, G Orend, ...
Oncotarget 5 (21), 10529, 2014
592014
The laminin response in inflammatory bowel disease: protection or malignancy?
C Spenle, O Lefebvre, J Lacroute, A Mechine-Neuville, F Barreau, ...
PloS one 9 (10), e111336, 2014
452014
Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide
L Jacob, P Sawma, N Garnier, LAT Meyer, J Fritz, T Hussenet, C Spenlé, ...
Oncotarget 7 (36), 57851, 2016
442016
Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma
D Muller, R Millon, S Théobald, T Hussenet, B Wasylyk, S Du Manoir, ...
British journal of cancer 94 (7), 1041, 2006
342006
Dysregulation of laminins in intestinal inflammation
C Spenlé, T Hussenet, J Lacroute, O Lefebvre, M Kedinger, G Orend, ...
Pathologie Biologie 60 (1), 41-47, 2012
272012
An adult tissue-specific stem cell molecular phenotype is activated in epithelial cancer stem cells and correlated to patient outcome
T Hussenet, D Dembélé, N Martinet, JM Vignaud, S du Manoir
Cell Cycle 9 (2), 321-327, 2010
192010
Phosphonated chelates for nuclear imaging
S Abada, A Lecointre, C Christine, L Ehret-Sabatier, F Saupe, G Orend, ...
Organic & biomolecular chemistry 12 (47), 9601-9620, 2014
142014
Overlapping 3q28 amplifications in the COMA cell line and undifferentiated primary sarcoma
T Hussenet, N Mallem, R Redon, B Jost, A Aurias, S du Manoir
Cancer genetics and cytogenetics 169 (2), 102-113, 2006
72006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20